Location: Boston, MA
CIK: 0001082621 · Show all filings
Period: Q1 2021 (← Previous) (Next →)
Filing Date: May 7, 2021
Total Value: $1.79B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RPRX | ROYALTY PHARMA PLC | 10,714,284 | $467M | 26.1% | — | — | SHS CLASS A | G7709Q104 |
| ICE | INTERCONTINENTAL EXCHANGE IN | 2,062,444 | $230M | 12.9% | — | — | COM | 45866F104 |
| ADBE | ADOBE SYSTEMS INCORPORATED | 326,100 | $155M | 8.7% | — | — | COM | 00724F101 |
| ABCL | ABCELLERA BIOLOGICS INC | 4,105,095 | $139M | 7.8% | — | — | COM | 00288U106 |
| META | FACEBOOK INC | 409,695 | $121M | 6.7% | — | — | CL A | 30303M102 |
| PANW | PALO ALTO NETWORKS INC | 340,900 | $110M | 6.1% | — | — | COM | 697435105 |
| LNWO | SCIENTIFIC GAMES CORP | 2,678,571 | $103M | 5.8% | — | — | COM | 80874P109 |
| MSFT | MICROSOFT CORP | 261,792 | $61.72M | 3.4% | — | — | COM | 594918104 |
| CRM | SALESFORCE COM INC | 164,622 | $34.88M | 1.9% | — | — | COM | 79466L302 |
| QQQ | INVESCO QQQ TR | 107,944 | $34.45M | 1.9% | — | — | UNIT SER 1 | 46090E103 |
| PCT | PURECYCLE TECHNOLOGIES INC | 1,276,267 | $32.55M | 1.8% | — | — | COM | 74623V103 |
| RVMD | REVOLUTION MEDICINES INC | 670,382 | $30.76M | 1.7% | — | — | COM | 76155X100 |
| IVV | ISHARES TR | 65,516 | $26.06M | 1.5% | — | — | CORE S&P500 ETF | 464287200 |
| — | PRAXIS PRECISION MEDICINES I | 778,517 | $25.5M | 1.4% | — | — | COM | 74006W108 |
| PLRX | PLIANT THERAPEUTICS INC | 562,379 | $22.12M | 1.2% | — | — | COM | 729139105 |
| RLAY | RELAY THERAPEUTICS INC | 541,124 | $18.71M | 1.0% | — | — | COM | 75943R102 |
| U | UNITY SOFTWARE INC | 186,396 | $18.7M | 1.0% | — | — | COM | 91332U101 |
| TXG | 10X GENOMICS INC | 89,476 | $16.2M | 0.9% | — | — | CL A COM | 88025U109 |
| SANA | SANA BIOTECHNOLOGY INC | 468,749 | $15.69M | 0.9% | — | — | COM | 799566104 |
| — | KINNATE BIOPHARMA INC | 498,001 | $15.52M | 0.9% | — | — | COM | 49705R105 |
| GLD | SPDR GOLD TR | 96,662 | $15.46M | 0.9% | — | — | GOLD SHS | 78463V107 |
| — | GENERATION BIO CO | 512,349 | $14.58M | 0.8% | — | — | COM | 37148K100 |
| RBLX | ROBLOX CORP | 197,642 | $12.81M | 0.7% | — | — | CL A | 771049103 |
| NRIX | NURIX THERAPEUTICS INC | 314,762 | $9.786M | 0.5% | — | — | COM | 67080M103 |
| VEA | VANGUARD TAX-MANAGED INTL FD | 175,937 | $8.64M | 0.5% | — | — | FTSE DEV MKT ETF | 921943858 |
| PDD | PINDUODUO INC | 42,490 | $5.689M | 0.3% | — | — | SPONSORED ADS | 722304102 |
| IJR | ISHARES TR | 50,304 | $5.459M | 0.3% | — | — | CORE S&P SCP ETF | 464287804 |
| — | NUCANA PLC | 992,405 | $4.952M | 0.3% | — | — | SPONSORED ADR | 67022C106 |
| FULC | FULCRUM THERAPEUTICS INC | 410,714 | $4.838M | 0.3% | — | — | COM | 359616109 |
| IJH | ISHARES TR | 16,129 | $4.198M | 0.2% | — | — | CORE S&P MCP ETF | 464287507 |
| VWO | VANGUARD INTL EQUITY INDEX F | 80,501 | $4.19M | 0.2% | — | — | FTSE EMR MKT ETF | 922042858 |
| — | FS DEVELOPMENT CORP II | 400,000 | $3.984M | 0.2% | — | — | COM CL A | 30318F100 |
| — | MAGENTA THERAPEUTICS INC | 332,610 | $3.938M | 0.2% | — | — | COM | 55910K108 |
| — | DECIBEL THERAPEUTICS INC | 328,798 | $3.735M | 0.2% | — | — | COM | 24343R106 |
| — | GEMINI THERAPEUTICS INC | 250,000 | $3.388M | 0.2% | — | — | COM | 36870G105 |
| — | SERES THERAPEUTICS INC | 131,847 | $2.715M | 0.2% | — | — | COM | 81750R102 |
| DYN | DYNE THERAPEUTICS INC | 107,252 | $1.666M | 0.1% | — | — | COM | 26818M108 |
| — | DADA NEXUS LTD | 49,887 | $1.354M | 0.1% | — | — | ADS | 23344D108 |